Creso Pharma (ASX:CPH) advantaged as UN reclassifies cannabis
ASX:CPH MCAP $43.37M
·Shares in Australian pharmaceutical cannabis company Creso Pharma (CPH) are up 27 per cent after the United Nations (UN) recognises marijuana as a less dangerous drug
·The United Nations Commission on Narcotic Drugs voted to downgrade marijuana from a Schedule IV substance to a Schedule I, the least restrictive classification
·The decision is expected to create multiple near term opportunities for the small-cap lister
·Creso touts the decision as a significant global trend towards relaxing access requirements to cannabis
·Shares in Creso are up 27 per cent and trading at 8 cents each
Creso Pharma (CPH) is set to benefit from a United Nations decision to withdraw marijuana's classification as a dangerous Schedule IV substance.
Cannabis will now be classified under Schedule I — the least restrictive drug classification — which the company says is a recognition of the potential medical properties of the drug.
It is anticipated the ruling will create numerous new near term opportunities for Creso.
Read the article on The Market Herald
- Forums
- ASX - By Stock
- CPH
- Creso Pharma (ASX:CPH) advantaged as UN reclassifies cannabis
Creso Pharma (ASX:CPH) advantaged as UN reclassifies cannabis
-
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online